Department of Chemical and Biomolecular Engineering (BK 21+ program), KAIST, Daehak-ro 291, Yuseong-gu, Daejeon 34141, Republic of Korea.
Nanoscale. 2021 Apr 21;13(15):7193-7201. doi: 10.1039/d1nr00438g. Epub 2021 Mar 15.
We, herein, describe a novel method to detect mutation in DNA by utilizing exponential amplification reaction (EXPAR) triggered by clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, called CRISPR-EXPAR. The CRISPR system consisting of two Cas9/sgRNA complexes was designed to cut out a specific mutation region within the target DNA, which would consequently promote EXPAR by continuously repeated extension and nicking reactions. As a consequence, a large number of final EXPAR products, which can be monitored through duplex-specific fluorescent staining, are produced. Based on this design principle, we successfully identified a model target mutation within the human epidermal growth factor receptor 2 (HER2) gene down to 437 aM with excellent specificity. The practical capability of this method was verified by reliably identifying the target mutation directly from the genomic DNA (gDNA) extracted from the lung cancer cell line, NCI-H1781 (H1781), and its universal applicability was further confirmed by identifying another EFGF L858R mutation. This technique could serve as a new isothermal platform to identify various mutations by rationally redesigning single guide RNA (sgRNA) according to the target mutation site.
我们在此描述了一种通过利用 CRISPR-Cas9 触发的指数扩增反应(EXPAR)来检测 DNA 突变的新方法,称为 CRISPR-EXPAR。该 CRISPR 系统由两个 Cas9/sgRNA 复合物组成,旨在切割靶 DNA 内的特定突变区域,从而通过连续的重复延伸和缺口反应来促进 EXPAR。结果,产生了大量的最终 EXPAR 产物,可以通过双链特异性荧光染色进行监测。基于这一设计原理,我们成功地在人类表皮生长因子受体 2(HER2)基因中鉴定出了一个模型靶突变,其检测下限低至 437 aM,具有优异的特异性。该方法的实际能力通过可靠地从肺癌细胞系 NCI-H1781(H1781)中提取的基因组 DNA(gDNA)中直接鉴定目标突变得到了验证,并且通过鉴定另一个 EFGF L858R 突变进一步证实了其普遍适用性。通过根据目标突变位点合理重新设计单指导 RNA(sgRNA),该技术可以作为一种新的等温平台来识别各种突变。